|
Volumn 100, Issue 1 A, 1996, Pages S62-S69
|
Results of a multicenter study of nebulized inhalant bronchodilator solutions
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
IPRATROPIUM BROMIDE;
ORCIPRENALINE;
PLACEBO;
THEOPHYLLINE;
BRONCHODILATING AGENT;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
ADULT;
AGED;
AREA UNDER THE CURVE;
BRONCHODILATING ACTIVITY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LUNG FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SMOKING;
SPIROMETRY;
WHEEZING;
ARTICLE;
TREATMENT OUTCOME;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-AGONISTS;
BRONCHODILATOR AGENTS;
CHOLINERGIC AGENTS;
DOUBLE-BLIND METHOD;
HUMANS;
IPRATROPIUM;
LUNG DISEASES, OBSTRUCTIVE;
ORCIPRENALINE;
QUALITY OF LIFE;
TREATMENT OUTCOME;
|
EID: 34547229866
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/s0002-9343(96)80109-4 Document Type: Conference Paper |
Times cited : (26)
|
References (0)
|